总时间（秒）：33.26
问答时间（秒）：31.51

<think>
Okay, let's tackle this query. The user wants information extracted from the given literature about parkin mutations in Parkinson's disease, structured in a specific JSON format. They mentioned using HGVS nomenclature and MONDO terms, so I need to make sure those are properly standardized.

First, I'll read through the abstract and the sections of the paper. The main points are about C-terminal and N-terminal parkin mutants. The C-terminal deletion causes loss of membrane association and aggregation. The N-terminal UBL domain mutations lead to proteasomal degradation. Also, there's a 42kDa parkin species from an internal start site without the UBL domain.

For variants, the paper mentions "Four N-terminal missense mutations" in the UBL domain. However, specific HGVS variants aren't provided in the text. The example given in the user's instruction used a specific variant, but here, the literature doesn't list exact nucleotide changes. That's a problem because the HGVS nomenclature requires specific positions. Since the text doesn't provide them, I'll have to use "N.D." as per the user's instructions.

Next, the disease is Parkinson's disease. I need to find the MONDO term. Parkinson's disease is MONDO:0005313. That's straightforward.

For the experimental methods, the study characterizes mutants through biochemical assays. The materials used are human brain extracts and cultured cells. The methods likely include techniques like Western blot, immunofluorescence, etc., but the abstract doesn't specify. The paper mentions "characterized pathogenic C- and N-terminal parkin mutants" and "deletion of the C terminus abrogated the association... induced rapid misfolding and aggregation." They also mention proteasomal degradation and the 42kDa species. However, without explicit mention of specific assays like Western blot or immunoprecipitation, I can't be certain. The user's example had "Western Blot," but the literature here doesn't specify. So, I'll need to use "N.D." for the assay method unless it's clearly stated.

The readout types would be qualitative (e.g., aggregation, degradation) and quantitative (e.g., protein levels). The results describe the effects of the variants, but without specific assays, it's hard to detail. The user's example included "Readout description" with variants, but again, without specific HGVS, this can't be filled. So, I'll have to put "N.D." where necessary.

For controls, the paper might have used wild-type as a positive control and mutants as negative, but it's not explicitly stated. So, again, "N.D." applies.

Approved assay: The methods described are standard in molecular biology for studying protein function, so I can say "Yes" for approved assay.

Putting it all together, the JSON will have "Variants Include" with gene "PARK2" (though the gene symbol for parkin is PARK2, but the paper might refer to it as PARKIN. Wait, the gene is called PARKIN, and the protein is parkin. So the gene symbol is PARK2. Need to confirm that. Yes, PARK2 is the correct gene symbol for parkin.

But the paper doesn't list specific variants, so variants under "Variants Include" will have "N.D." for HGVS and protein changes. However, the user's example had "Description in input context" even if HGVS was missing. Wait, in the example, they used the variant description as given in the input. But here, the paper mentions "Four N-terminal missense mutations in the UBL domain" but doesn't specify which ones. So I can only note that in the description, but HGVS will be N.D.

So the variants section would have the gene as PARK2, and variants with N.D. for HGVS, cDNA, and protein changes, but the description would be "Four N-terminal missense mutations in the UBL domain" and the 42kDa species from an internal start site.

For the experiments, the methods are characterization through biochemical assays, but without specific techniques, so "Assay Method" is N.D. However, the example used "Western Blot," but the literature here doesn't mention it. So I can't assume that. Therefore, "N.D." is appropriate.

The MONDO term is MONDO:0005313 for Parkinson's disease.

In summary, the JSON will have the variants with N.D. for HGVS, the disease with MONDO term, and experiments with N.D. for most fields except approved assay, which is "Yes" since the methods are standard.
</think>

{
  "Variants Include": [
    {
      "Gene": "PARK2",
      "variants": [
        {
          "HGVS": "N.D.",
          "cDNA Change": {
            "transcript": "N.D.",
            "ref": "N.D.",
            "alt": "N.D.",
            "position": "N.D."
          },
          "Protein Change": {
            "ref": "N.D.",
            "alt": "N.D.",
            "position": "N.D."
          },
          "Description in input context": "Four N-terminal missense mutations in the UBL domain; deletion of the C terminus; 42kDa parkin species from an internal start site without the UBL domain."
        }
      ]
    }
  ],
  "Described Disease": {
    "Described Disease": "Parkinson's disease",
    "MONDO": "MONDO:0005313"
  },
  "Experiment Method": [
    {
      "Assay Method": "N.D.",
      "Material used": {
        "Material Source": "Human brain extracts and cultured cells",
        "Material Name": "N.D.",
        "Description": "Characterization of pathogenic C- and N-terminal parkin mutants; analysis of proteasomal degradation and 42kDa parkin species."
      },
      "Readout type": "N.D.",
      "Readout description": [
        {
          "Variant": "N.D.",
          "Conclusion": "N.D.",
          "Molecular Effect": "N.D.",
          "Result Description": "C-terminal deletion abrogates membrane association, induces misfolding/aggregation; N-terminal UBL mutations lead to proteasomal degradation; 42kDa parkin species lacks UBL domain."
        }
      ],
      "Biological replicates": {
        "Biological replicates": "N.D.",
        "Description": "N.D."
      },
      "Technical replicates": {
        "Technical replicates": "N.D.",
        "Description": "N.D."
      },
      "Basic positive control": {
        "Basic positive control": "N.D.",
        "Description": "N.D."
      },
      "Basic negative control": {
        "Basic negative control": "N.D.",
        "Description": "N.D."
      },
      "Validation controls P/LP": {
        "Validation controls P/LP": "N.D.",
        "Counts": "N.D."
      },
      "Validation controls B/LB": {
        "Validation controls B/LB": "N.D.",
        "Counts": "N.D."
      },
      "Statistical analysis method": {
        "Statistical analysis method": "N.D."
      },
      "Threshold for normal readout": {
        "Threshold for normal readout": "N.D.",
        "Source": "N.D."
      },
      "Threshold for abnormal readout": {
        "Threshold for abnormal readout": "N.D.",
        "Source": "N.D."
      },
      "Approved assay": {
        "Approved assay": "Yes"
      }
    }
  ]
}